ALLKEM LIMITED (AKE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

AKE - ALLKEM LIMITED

FNArena Sector : New Battery Elements
Year End: June
GICS Industry Group : NONE
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$12.10

10 Aug
2022

0.050

OPEN

$12.00

0.41%

HIGH

$12.25

2,952,802

LOW

$11.88

TARGET
$14.51 19.9% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
AVZ . KDR . GXY . MNS . SYR . PLS . NMT . JRV . LKE . VUL . TLG . SRL . LPI . BSX . CLQ . AJM . NVX . BSM . INR . A4N . LTR . PLL . LPD . CXO . PSC . GLN . GT1 . GL1 . AGY . SYA . EMN .
FNARENA'S MARKET CONSENSUS FORECASTS
AKE: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx - 24.2 60.0 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 20.8 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A 0.0% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx-24.2
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx113.6 M
Book Value Per Share xxxxxxxxxxxxxxx258.0
Net Operating Cash Flow xxxxxxxxxxxxxxx-21.0 M
Net Profit Margin xxxxxxxxxxxxxxx-70.35 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx-9.07 %
Return on Invested Capital xxxxxxxxxxxxxxx-6.57 %
Return on Assets xxxxxxxxxxxxxxx-4.62 %
Return on Equity xxxxxxxxxxxxxxx-9.07 %
Return on Total Capital xxxxxxxxxxxxxxx0.39 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-150.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.7

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

21/07/2022

3

Neutral

$10.40

-14.05%

Allkem realeased FY22 sales revenue and operating profits of $594m, in-line with Credit Suisse estimates.

The broker notes the transition of Mt Cattlin lowers the FY23 spodumene guidance to 1160-170kt which is below expectations and consensus forecasts.

The company offers no guidance for Olaroz; the James Bay project delay with construction now to start in the March quarter of 2023; Sal de Vida expects initial production in 2H23.

Credit Suisse lowers earnings forecasts from increasing costs at Mt Cattlin and project delays.

Target price for Allkem has been reduced to $10.40 from $11.00. Neutral rating.

FORECAST
Credit Suisse forecasts a full year FY22 dividend of 0.00 cents and EPS of 74.69 cents.
Credit Suisse forecasts a full year FY23 dividend of 75.65 cents and EPS of 151.31 cents.

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

AKE STOCK CHART